Skip to main content

Table 1 Timing of echocardiographic and biomarker assessments

From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate

t0

t1

t2

t3

t4

Before EPI

week 1

week 4

week 7

week 10

For EPI dose other than 100 ± 30 mg/m2 every three weeks

t 0

t 1

t 2

t 3

t 4

Before EPI

1 week after reaching 100 ± 30 mg/m2

1 week after reaching 200 ± 30 mg/m2

1 week after reaching 300 ± 30 mg/m2

1 week after reaching 400 ± 30 mg/m2

  1. For EPI dose 100 ± 30 mg/m2 every three weeks.